These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23189156)

  • 1. Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis.
    van Schaik FD; Gadaleta RM; Schaap FG; van Mil SW; Siersema PD; Oldenburg B; van Erpecum KJ
    PLoS One; 2012; 7(11):e49706. PubMed ID: 23189156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor.
    Gadaleta RM; Garcia-Irigoyen O; Cariello M; Scialpi N; Peres C; Vetrano S; Fiorino G; Danese S; Ko B; Luo J; Porru E; Roda A; Sabbà C; Moschetta A
    EBioMedicine; 2020 Apr; 54():102719. PubMed ID: 32259714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obeticholic acid may increase the risk of gallstone formation in susceptible patients.
    Al-Dury S; Wahlström A; Panzitt K; Thorell A; Ståhlman M; Trauner M; Fickert P; Bäckhed F; Fändriks L; Wagner M; Marschall HU
    J Hepatol; 2019 Nov; 71(5):986-991. PubMed ID: 31254596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's disease.
    Wilson A; Almousa A; Teft WA; Kim RB
    Sci Rep; 2020 Feb; 10(1):1866. PubMed ID: 32024859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis.
    Ho PP; Steinman L
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1600-5. PubMed ID: 26811456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages.
    Cao S; Meng X; Li Y; Sun L; Jiang L; Xuan H; Chen X
    Front Immunol; 2021; 12():632864. PubMed ID: 33968024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
    Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
    Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG
    Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids.
    Zhang JH; Nolan JD; Kennie SL; Johnston IM; Dew T; Dixon PH; Williamson C; Walters JR
    Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(10):G940-8. PubMed ID: 23518683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
    Chignard N; Mergey M; Barbu V; Finzi L; Tiret E; Paul A; Housset C
    Hepatology; 2005 Sep; 42(3):549-57. PubMed ID: 16037943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model.
    Villalona G; Price A; Blomenkamp K; Manithody C; Saxena S; Ratchford T; Westrich M; Kakarla V; Pochampally S; Phillips W; Heafner N; Korremla N; Greenspon J; Guzman MA; Kumar Jain A
    JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1238-1251. PubMed ID: 29701901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bile acid receptor FXR is a modulator of intestinal innate immunity.
    Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19.
    Miyata M; Hata T; Yamakawa H; Kagawa T; Yoshinari K; Yamazoe Y
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):41-7. PubMed ID: 22561792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity.
    Mencarelli A; Cipriani S; Renga B; D'Amore C; Palladino G; Distrutti E; Baldelli F; Fiorucci S
    Nutr Metab Cardiovasc Dis; 2013 Feb; 23(2):94-101. PubMed ID: 21924881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms.
    Guo C; LaCerte C; Edwards JE; Brouwer KR; Brouwer KLR
    J Pharmacol Exp Ther; 2018 May; 365(2):413-421. PubMed ID: 29487110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.
    Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A
    Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence.
    Simbrunner B; Hofer BS; Schwabl P; Zinober K; Petrenko O; Fuchs C; Semmler G; Marculescu R; Mandorfer M; Datz C; Trauner M; Reiberger T
    Hepatol Int; 2024 Jun; 18(3):929-942. PubMed ID: 38332428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.